Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Nørgaard, P., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W.-C.
& D'Amore, F. A. (2014).
Identification of a subset of peripheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome.
Blood,
124(21).
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W. C.
& D'Amore, F. A. (2014).
Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. .
Blood,
124(21), Article 124.
Kilpivaara, O., Ristolainen, H.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, D'Amore, F. A. & Lauri, A. A. (2014).
Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma with exome sequencing.
Blood,
121(24).
D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D.
, Clausen, M. R., Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S.
& Toldbod, H. (2014).
Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas.
Blood,
124(21).
Ludvigsen, M., Pedersen, M. B., Poulsen, T. S.
, Hamilton-Dutoit, S. J., Besenbacher, S.
, Bendix, K., Møller, M. B.
, D'Amore, F. A. & Honoré, B. (2014).
Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified.
Blood,
124(21), Article 124.
Abrahamsson, A., Albertsson-Lindblad, A., Brown, P. N., Baumgartner-Wennerholm, S., Pedersen, L. M.
, D'Amore, F., Nilsson-Ehle, H.
, Jensen, P., Pedersen, M., Geisler, C. H. & Jerkeman, M. (2014).
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Blood,
124(8), 1288-95.
https://doi.org/10.1182/blood-2014-03-559930El-Galaly, T. C., Mylam, K. J.
, Bøgsted, M., Brown, P. D. N., Rossing, M., Gang, A. O., Haglund, A., Arboe, B.
, Clausen, M. R., Jensen, P., Pedersen, M., Bukh, A., Jensen, B. A., Poulsen, C. B., d'Amore, F. & Hutchings, M. (2014).
Role of routine imaging in detecting recurrent lymphoma; a review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
American Journal of Hematology,
89(6), 575-580.
https://doi.org/10.1002/ajh.23688
D'Amore, F. A., Gaulard, P., Trümper, L., Corradini, P., Kim, W.-S., Specht, L.
& Pedersen, M. B. (2014).
T-cell lymphoma:L ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow up.
Annals of Oncology.
Coiffier, B., Federico, M., Caballero, D., Dearden, C., Morschhauser, F., Jäger, U., Trümper, L., Zucca, E., Gomes da Silva, M., Pettengell, R., Weidmann, E.
, d'Amore, F., Tilly, H. & Zinzani, P. L. (2014).
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Cancer Treatment Reviews,
40(9), 1080-1088.
https://doi.org/10.1016/j.ctrv.2014.08.001Vase, M. Ø., Maksten, E. F.
, Bendix, K., Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J., Rabinovich, G. A.
, Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014).
Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder.
Blood,
124(21).
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia.
British Journal of Dermatology,
169(2), 469-472.
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (alz) is effective against severe chronic lymphocytic leukemia-associated paraneoplastic pemphigus (pnp).
British Journal of Dermatology,
169(2).
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, NA.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is effective against severe paraneoplastic pemphigus (PNP).
British Journal of Dermatology.
Bech, M. R.
, Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Deleuran, M. & d'Amore, F. (2013).
Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
British Journal of Dermatology,
169(2), 469-72.
https://doi.org/10.1111/bjd.12324Vase, M. Ø., Friis, S., Bautz, A.
, Bendix, K., Sørensen, H. T. & d'Amore, F. (2013).
Breast implants and anaplastic large cell lymphoma: A Danish population-based cohort study.
Cancer Epidemiology, Biomarkers & Prevention,
22(11), 2126-2129.
https://doi.org/10.1158/1055-9965.EPI-13-0633
Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C. M., Caligaris-Cappio, F., Stilgenbauer, S., Marcus, R., Trneny, M., Dreger, P., Montserrat, E., Dreyling, M., Agostinelli, C., Arcaini, L., Campo, E. ... Zucca, E. (2013).
Esmo Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
Annals of Oncology,
24(3), 561-76.
Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, LM., Iqbal, J., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H.
, D'Amore, F. A., Leppa, S., Liu, W., McKeithan, T. & Chan, WC. (2013).
Frequent activating mutations of JAK-Stat Pathway genes in natural killer cell lymphomas.
Blood.
Vase, M. Ø., Larsen, C. S., Bendix, K., Hamilton-Dutoit, S. J., Moeller, M. B.
& D'Amore, F. A. (2013).
Hiv-associated lymphoma in Western Denmark: Higher frequency of Burkitt histology and primary extranodal non-CNS presentation in the post-as compared to the pre-HAART ERA.
Hematological Oncology,
31, 216-217.
Snipsøyr, M. G., Wiggers, H., Knudsen, J. B., Ludvigsen, M., Poulsen, S. H., Petersen, E. & Honoré, B. (2013).
Identification of putative, novel biomarkers for infective endocarditis by proteomic analysis. Poster session presented at 30th annual meeting of Nordic Society of Clinical Microbiology and Infectious Diseases, Aarhus, Denmark.
El-Galaly, T. C., Hutchings, M., Mylam, K. J., de Nully Brown, P.
, Bukh, A., Johnsen, H. E., Kamper, P., Loft, A.
, Iyer, V., Gormsen, L. C., Nielsen, A. L., Bøgsted, M. & d'Amore, F. (2013).
Impact of 18F-FDG PET/CT Staging in Newly Diagnosed Classical Hodgkin Lymphoma: Less Cases with Stage I Disease and More with Skeletal Involvement.
Leukemia and Lymphoma.
https://doi.org/10.3109/10428194.2013.875169
Wästerlid, T., Brown, P. D. N., Hagberg, O., Hagberg, H., Pedersen, LM.
, D'Amore, F. A. & Jerkeman, M. (2013).
Impact of chemotherapy regimen and rituximab in adult Burkitt Lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Annals of Oncology,
24(7), 1879-1886.
D'Amore, F. A., Lauritzsen, G. F., Relander, T., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U., Gadeberg, O., Sundstrom, C., Delabie, J., Ralfkiaer, E., Vornanen, M.
& Toldbod, H. (2013).
Late relapses in peripheral T-cell lymphoma patients treated in the nordic NLG-T-01 trial.
Hematological Oncology,
31, 176-177.
Vase, M. Ø., S, E. F.
, Bendix, K., Jespersen, B., Hamilton-Dutoit, S. J., Schwartz, S., Andersen, C.
& D'Amore, F. A. (2013).
Monomorphic PTLD in a danish cohort: HLA tissue subtype matching correlates with survival.
Hematological Oncology,
31, 216.
El-Galaly, T. C., Mylam, K., Brown, P., Rossing, M., Gang, A., Haglund, A., Arboe, B., Clausen, M., Jensen, P., Pedersen, M.
, Bukh, A., Amdi Jensen, B., Poulsen, C.
, D'Amore, F. A. & Hutchings, M. (2013).
Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse.
Hematological Oncology,
31.
Ludvigsen, M., Madsen, C.
, Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies differential expression patterns in follicular lymphoma patients with or without subsequent histological transformation.
Hematological Oncology,
31, 203.
Ludvigsen, M., Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Moeller, M. B., Noergaard, P.
, D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Hematological Oncology,
31, 174-175.
Gang, AO., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2013).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. An updated analysis with 5 years median follow-up of the population-based investigation from the Danish Lymphoma Group.
Hematological Oncology (Online),
31(suppl 1), 167-168.
https://doi.org/10.1002/hon.2058Johnson, P., Federico, M., Fossa, A., O'Doherty, M., Roberts, T., Stevens, L., Smith, P., Kirkwood, A., Anghe, G., Trotman, J., Berkahn, L.
, D'Amore, F. A., Enblad, G., Luminari, S., Viney, Z., Radford, J. & Barrington, S. (2013).
Responses and chemotherapy dose adjustment determined by PET-CT imaging: First results from the international response adapted therapy in advanced hodgkin lymphoma (RATHL) study.
Hematological Oncology,
31, 138.
Ludvigsen, M., Kamper, P., Sørensen, B. S., Hamilton Dutoit, S. J., Bendix, K., Møller, M. B.
, Alsner, J., D'Amore, F. A. & Honoré, B. (2013).
Specific degradation pattern of peroxiredoxin-1 correlates with adverse outcome in classical Hodgkin lymphoma patients..
Andersen, MP.
, Kamper, P., Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S. J., D'Amore, F. A. & Clausen, MR. (2013).
The number of tumour-infiltrating mast cells correlates with adverse prognosis in mixed cellularity, but not nodular sclerosis type, classical Hodgkin lymphoma.
Haematologica.
Madsen, C.
, Pedersen, M. B., Segel, E.
, Bendix, K., Jensen, B. A., Jensen, P., Moelller, M. B., Johansen, P., Munksgaard, L., Brown, P.
& D'Amore, F. A. (2013).
upfront autologous stem-cell transplantation in transformed indolent non-hodgkins lymphoma: An outcome analysis.
Hematological Oncology,
31.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Pittaluga, S., Jaffe, E. & Wilson, W. H. (2012).
Alemtuzumab (ALZ) in combination with Dose-Adjusted EPOC (DA-EPOCH) has higher efficacy in nodal than in extranodal or leukemic peripheral T-cell lymphoma.
International Journal of Clinical Oncology.
Gang, AO., Pedersen, M.
, D'Amore, F. A., Møller-Pedersen, L., Pedersen, BA., Jensen, P., Pedersen, BB., Møller, MB., Gadeberg, O. V., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S., Klausen, TW. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO.
Blood,
120(21).
Pedersen, M.
, D'Amore, F. A., Pedersen, L. M., Jensen, B. A.
, Jensen, P., Pedersen, B. B., Møller, M. B., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S., Klausen, T. W. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, United States.
El-Galaly, T. C., Hutchings, M., Juul Mylam, K., Brown, P. D. N.
, Bukh, A., Kamper, P., Johnsen, H. E. & D'Amore, F. A. (2012).
Clinical Features and Outcome in Newly Diagnosed Hodgkin Lymphoma Patients Presenting with PET/CT-Ascertained Focal Skeletal Lesions.
Vase, M. Ø., Hellberg, Y., larsen, C. S.
, Petersen, E., Schaumburg, H.
, Bendix, K., Ravel, C., Bastien, P.
, Christensen, M. & D'Amore, F. A. (2012).
Development of a splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica,
128(1), 20-22.
Vase, M. Ø., Hellberg, Y. K.
, Larsen, C. S., Petersen, E., Schaumburg, H.
, Bendix, K., Ravel, C., Bastien, P.
, Christensen, M. & d'Amore, F. (2012).
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica Polonica,
128(1), 20-2.
https://doi.org/10.1159/000337341
El-Galaly, T. C., Juul Mylam, K., Brown, P. D. N.
, Bukh, A., Johnsen, H. E., Madsen, C.
, D'Amore, F. A. & Hutchings, M. (2012).
Disease Extent in Newly Diagnosed Hodgkin Lymphoma: A Comparison of CT and PET/CT Staged Patients.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Maryalice, S. S., Pittaluga, S., Jaffe, E. S. & Wilson, W. H. (2012).
Efficacy of alemtuzumab (ALZ) in combination with dose-ajusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma.
Journal of Clinical Oncology,
30(15).
Kamper, P., Bendix, K., Honoré, B., D'Amore, F. A. & Hamilton-Dutoit, S. J. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, GA, United States.
Kamper, P., Bendix, K., Hamilton-Dutoit, S. J., Honoré, B. & D'Amore, F. A. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma.
Blood,
120(21), Article 120.
D'Amore, F. A., Leppä, S., Gomes da Silva, M., Relander, T., Brown, P. D. N., Weidmann, E., Lauritzsen, GF., Pezzutto, A., Van Hoof, A., Van Gelder, M., Doorduijn, J., Wu, KL., Kluin-Nelemans, JC., Lugtenburg, PJ., Jankovska, M., Merup, M., Fagerli, U.-M., Walewski, J., Hagberg, H. ... Toldbod, H. (2012).
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy.
Blood,
120(57).
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. (2012).
High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma - final analysis of a large prospective multicenter study (NLG-T-01).
Blood,
118, 331.
Gang, AO., Stroem, C., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mortensen, L. S., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2012).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology,
23(1), 147-153.
https://doi.org/10.1093/annonc/mdr058El-Galaly, T. C., d'Amore, F., Mylam, K. J., de Nully Brown, P.
, Bøgsted, M., Bukh, A., Specht, L., Loft, A.
, Iyer, V., Hjorthaug, K., Nielsen, A. L., Christiansen, I., Madsen, C., Johnsen, H. E. & Hutchings, M. (2012).
Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography-Staged Treatment-Naive Patients With Hodgkin Lymphoma.
Journal of Clinical Oncology,
30(36), 4508-4514.
https://doi.org/10.1200/JCO.2012.42.4036